HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dirk De Ruysscher Selected Research

Cranial Irradiation

7/2021Shared decision-making for prophylactic cranial irradiation in extensive-stage small-cell lung cancer: an exploratory study.
1/2020The role of postoperative thoracic radiotherapy and prophylactic cranial irradiation in early stage small cell lung cancer: Patient selection among ESTRO experts.
1/2019Prophylactic cranial irradiation in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO experts.
10/2018Prophylactic Cranial Irradiation Versus Observation in Radically Treated Stage III Non-Small-Cell Lung Cancer: A Randomized Phase III NVALT-11/DLCRG-02 Study.
1/2016Prophylactic cranial irradiation for patients with lung cancer.
12/2015Phase III Study of Surgery Versus Definitive Concurrent Chemoradiotherapy Boost in Patients With Resectable Stage IIIA(N2) and Selected IIIB Non-Small-Cell Lung Cancer After Induction Chemotherapy and Concurrent Chemoradiotherapy (ESPATUE).
3/2013State of the art radiation therapy for lung cancer 2012: a glimpse of the future.
2/2012A practical technique to avoid the hippocampus in prophylactic cranial irradiation for lung cancer.
9/2006Omission of elective node irradiation on basis of CT-scans in patients with limited disease small cell lung cancer: a phase II trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dirk De Ruysscher Research Topics

Disease

75Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2023 - 07/2002
70Neoplasms (Cancer)
12/2023 - 03/2006
45Lung Neoplasms (Lung Cancer)
02/2024 - 07/2002
16Small Cell Lung Carcinoma (Small Cell Lung Cancer)
07/2021 - 12/2005
10Neoplasm Metastasis (Metastasis)
12/2023 - 10/2012
8Brain Neoplasms (Brain Tumor)
04/2024 - 09/2010
7Prostatic Neoplasms (Prostate Cancer)
01/2023 - 05/2007
7Hypoxia (Hypoxemia)
03/2020 - 06/2007
6Pneumonia (Pneumonitis)
01/2023 - 06/2014
5Breast Neoplasms (Breast Cancer)
11/2023 - 12/2016
5Dyspnea (Shortness of Breath)
01/2019 - 06/2009
4Malignant Mesothelioma
01/2020 - 09/2003
4Deglutition Disorders (Dysphagia)
01/2019 - 12/2010
3Disease Progression
01/2022 - 09/2006
3Inflammation (Inflammations)
01/2022 - 10/2011
3Esophagitis
06/2014 - 03/2006
2Fatigue
11/2023 - 10/2023
2AIDS-Related Complex (ARC)
10/2023 - 01/2016
2Radiation Pneumonitis
01/2023 - 01/2019
2Thymoma (Thymic Carcinoma)
11/2022 - 12/2021
2Atrophy
10/2022 - 09/2004
2Erythema
10/2022 - 01/2020
2Fibrosis (Cirrhosis)
09/2020 - 01/2017
1Overweight
04/2024
1Obesity
04/2024
1Anemia
11/2023
1Lymphopenia (Lymphocytopenia)
11/2023
1Sleep Initiation and Maintenance Disorders (Insomnia)
11/2023
1Pain (Aches)
11/2023
1Genetic Risk Score
11/2022
1Myasthenia Gravis
11/2022
1Cachexia
01/2022
1Margins of Excision
11/2021
1Second Primary Neoplasms (Neoplasms, Second)
03/2021
1Glioblastoma (Glioblastoma Multiforme)
01/2021
1Vomiting
01/2021
1Nausea
01/2021
1Lung Injury
01/2021
1Circulating Neoplastic Cells
01/2020
1Adenocarcinoma of Lung
10/2019
1Esophageal Neoplasms (Esophageal Cancer)
01/2019
1Cardiotoxicity
01/2019
1Thoracic Diseases
01/2019
1Radiation Fibrosis Syndrome (Radiation Fibrosis)
01/2019

Drug/Important Bio-Agent (IBA)

9Biomarkers (Surrogate Marker)IBA
01/2023 - 09/2004
6Immune Checkpoint InhibitorsIBA
12/2023 - 01/2019
5Protons (Proton)IBA
04/2024 - 07/2009
5durvalumabIBA
11/2023 - 01/2022
4Cisplatin (Platino)FDA LinkGeneric
10/2020 - 07/2002
4Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
12/2019 - 04/2008
3AntigensIBA
01/2023 - 01/2015
33- fluoro- 2- (4- ((2- nitro- 1H- imidazol- 1- yl)methyl)- 1H- 1,2,3- triazol- 1- yl)propan- 1- olIBA
12/2020 - 08/2010
2SDMIBA
01/2022 - 07/2021
2Proteins (Proteins, Gene)FDA Link
12/2021 - 01/2020
2Dihydrotachysterol (AT 10)IBA
10/2019 - 10/2006
2Cetuximab (Erbitux)FDA Link
01/2017 - 01/2016
2Carbon MonoxideIBA
11/2016 - 03/2010
2Deoxyglucose (2 Deoxy D glucose)IBA
12/2014 - 10/2012
2CarbonIBA
04/2010 - 04/2010
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2023
1ORALIT (ORS)IBA
11/2022
1Muscle Proteins (Muscle Protein)IBA
01/2022
1NivolumabIBA
01/2022
1IpilimumabIBA
01/2022
1Temozolomide (Temodar)FDA LinkGeneric
01/2021
1isocitrate dehydrogenase (NADP+)IBA
01/2021
1epidermal growth factor receptor VIIIIBA
01/2021
1Interleukin-2 (IL2)IBA
01/2021
1Fibronectins (Fibronectin)IBA
01/2021
1Chloroquine (Aralen)FDA LinkGeneric
01/2021
1ErbB Receptors (EGF Receptor)IBA
01/2021
1Hydroxychloroquine (Plaquenil)FDA LinkGeneric
01/2021
1MethyltransferasesIBA
01/2021
1Radiation-Sensitizing AgentsIBA
10/2020
1Nitroglycerin (Dynamite)FDA LinkGeneric
03/2020
1Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2020
1DNA (Deoxyribonucleic Acid)IBA
01/2020
1AnthracyclinesIBA
01/2020
1Bortezomib (Velcade)FDA Link
01/2020
1Messenger RNA (mRNA)IBA
01/2020
1TamoxifenFDA LinkGeneric
01/2020
1C-Reactive ProteinIBA
07/2018

Therapy/Procedure

124Radiotherapy
04/2024 - 07/2002
22Drug Therapy (Chemotherapy)
04/2024 - 07/2002
20Therapeutics
11/2023 - 05/2007
11Immunotherapy
12/2023 - 01/2015
9Cranial Irradiation
07/2021 - 09/2006
6Chemoradiotherapy
01/2022 - 06/2009
5Re-Irradiation
02/2024 - 12/2014
4Proton Therapy
05/2016 - 01/2010
2Aftercare (After-Treatment)
11/2023 - 01/2018
2Induction Chemotherapy
11/2021 - 12/2015
2Precision Medicine
01/2020 - 12/2017
2Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
11/2018 - 12/2016
1Adjuvant Radiotherapy
11/2023
1Brachytherapy
01/2023
1Thymectomy
11/2022
1Nutritional Support (Artificial Feeding)
01/2022
1Adjuvant Chemotherapy
11/2021
1Segmental Mastectomy (Lumpectomy)
01/2020